Alliance Pharma PLC Notification of Half Year Trading Update (8576D)
July 12 2016 - 2:00AM
UK Regulatory
TIDMAPH
RNS Number : 8576D
Alliance Pharma PLC
12 July 2016
For immediate release 12 July 2016
ALLIANCE PHARMA PLC
("Alliance" or the "Company")
Notification of Half Year Trading Update
Alliance Pharma plc (AIM: APH), the specialty pharmaceutical
company, will release its half year trading update for the 6 months
ended 30 June 2016 on Tuesday 19 July 2016.
For further information:
Alliance Pharma plc + 44 (0) 1249 466966
John Dawson, Chief Executive
Andrew Franklin, Chief Financial
Officer
Sarah Robinson, Company Secretary
www.alliancepharma.co.uk
+ 44 (0) 20 7466
Buchanan 5000
Mark Court / Sophie Cowles
/ Jane Glover
+ 44 (0) 20 7260
Numis Securities Limited 1000
Nominated Adviser: Michael
Meade / Freddie Barnfield
Corporate Broking: James
Black / Toby Adcock
Notes to editors:
About Alliance Pharma
Alliance, founded in 1998, is an international specialty
pharmaceutical company based in Chippenham, Wiltshire, UK. The
Company has sales in more than 100 countries worldwide via direct
sales, joint ventures and a network of distributors. Alliance has a
strong track record of acquiring the rights to established niche
products and it currently owns or licenses the rights to
approximately 90 pharmaceutical and consumer healthcare products.
The Company continues to explore opportunities to expand its
product portfolio.
Alliance joined the AIM market of the London Stock Exchange in
December 2003 and trades under the symbol APH.
This information is provided by RNS
The company news service from the London Stock Exchange
END
NOREASXFFAPKEFF
(END) Dow Jones Newswires
July 12, 2016 02:00 ET (06:00 GMT)
Alliance Pharma (LSE:APH)
Historical Stock Chart
From Aug 2024 to Sep 2024
Alliance Pharma (LSE:APH)
Historical Stock Chart
From Sep 2023 to Sep 2024